← Explorer/Network

Onset of mucosal, dermal, and general symptoms in relation to biomarkers and exposures in the dwelling: a cohort study from 1992 to 2002

Bo Sahlberg, Dan Norbäck, Gunilla Wieslander +2 more2012Indoor AirCohort study
10.1111/j.1600-0668.2012.00766.xPubMedFree full text
DermatologicalImmune/InnateRespiratory/Sinus
Indoor Mold (Stachybotrys, Aspergillus, etc.)Water-Damaged Buildings (WDB)

Abstract

UNLABELLED: We examined the associations between biomarkers of allergy and inflammation, indoor environment in dwellings, and incidence and remission of symptoms included in the sick building syndrome (SBS) and changes in the home environment of 452 adults who were followed from 1992 to 2002 within the Uppsala part of the European Community Respiratory Health Survey (ECRHS). The 10-year incidence (onset) of general, mucosal, and dermal symptoms was 8.5%, 12.7%, and 6.8%, respectively. Dampness or indoor molds at baseline was a predictor of incidence of general (relative risk [RR] = 1.98), mucosal (RR = 2.28), and dermal symptoms (RR = 1.91). Women had higher incidence of general (RR = 1.74) and mucosal symptoms (RR = 1.71). Indoor painting increased the incidence of general symptoms (RR = 1.62). Bronchial responsiveness (BR), eosinophil counts in blood, total IgE and eosinophilic cationic protein (ECP) in serum at baseline were predictors of incidence of SBS. At follow-up, BR, total IgE, and C-reactive protein (CRP ) were associated with increased incidence of SBS. Moreover, subjects with doctor-diagnosed asthma at baseline had a higher incidence of general (RR = 1.65) and mucosal symptoms (RR = 1.97). In conclusion, female gender, dampness or indoor molds, indoor painting, and biomarkers of allergy and inflammation were associated with a higher incidence of SBS symptoms, in particular mucosal symptoms. PRACTICAL IMPLICATIONS: The focus in Sweden on indoor environment issues over the last few decades has resulted in improvements in dwellings, and reduced tobacco smoking, which could be beneficial for public health. Reducing dampness and molds in the dwelling place is another important way of reducing occurrence of SBS symptoms in the general adult population. The association between the incidence of SBS symptoms and clinical biomarkers of allergy and inflammation suggests a common etiology between inflammatory diseases, including asthma, rhinitis, and SBS. Lastly, good agreement between self-reported and clinically diagnosed atopy indicates that questionnaire data on atopy can be used in epidemiological studies.

Symptom Clusters

Dermal symptomsRespiratory symptoms

Cited By (13)

  • Indoor microbiome and allergic diseases: From theoretical advances to prevention strategiesEco-Environment & Health · 2022
  • Dampness and mould in Chinese homes and sick building syndrome (SBS) symptoms – Associations with climate, family size, cleaning and ventilationBuilding and Environment · 2023
  • Medizinisch klinische Diagnostik bei Schimmelpilzexposition in Innenräumen – Update 2023 (AWMF-Register-Nr. 161/001)Pneumologie · 2024
  • What effect do mycotoxins, cell wall components, enzymes and other mold components and metabolites have on our health?Allergo Journal International · 2024
  • Onset characteristics and breadth of occupants’ long-lasting building-related symptoms attributed to living in damp housing conditions in Australia: Qualitative insightsBuilding and Environment · 2024
  • Associations between indoor environment in residential buildings in wet and dry seasons and health of students in upper northern ThailandIndoor Air · 2021

Related Papers

  • Dampness and moulds in workplace buildings: Associations with incidence and remission of sick building syndrome (SBS) and biomarkers of inflammation in a 10 year follow-up studyThe Science of The Total Environment · 2012 · 5 shared tags
  • Poorly controlled asthma – Easy wins and future prospects for addressing fungal allergyAllergology International · 2023 · 5 shared tags
  • The Sick Building Syndrome as a Part of the Autoimmune (Autoinflammatory) Syndrome Induced by Adjuvant2024 · 5 shared tags
  • Medizinisch klinische Diagnostik bei Schimmelpilzexposition in Innenräumen – Update 2023 (AWMF-Register-Nr. 161/001)Pneumologie · 2024 · 5 shared tags
  • Clinical experience and results of a sentinel health investigation related to indoor fungal exposureEnvironmental Health Perspectives · 1999 · 5 shared tags
  • Adverse human health effects associated with molds in the indoor environmentJournal of Occupational and Environmental Medicine · 2003 ·
Fungal exposome, human health, and unmet needs: A 2022 update with special focus on allergy
Allergy · 2022
  • TFOS Lifestyle Report: Impact of environmental conditions on the ocular surfaceThe Ocular Surface · 2023
  • How do mycotoxins, cell wall components, enzymes, other mold components and mold metabolites affect health?Allergo Journal · 2024
  • Dampness and mold in homes across China: Associations with rhinitis, ocular, throat and dermal symptoms, headache and fatigue among adultsIndoor Air · 2019
  • Rhinitis, Ocular, Throat and Dermal Symptoms, Headache and Tiredness among Students in Schools from Johor Bahru, Malaysia: Associations with Fungal DNA and Mycotoxins in Classroom DustPLoS ONE · 2016
  • SBS symptoms in relation to dampness and ventilation in inspected single-family houses in SwedenInternational Archives of Occupational and Environmental Health · 2017
  • Dampness and moulds in workplace buildings: Associations with incidence and remission of sick building syndrome (SBS) and biomarkers of inflammation in a 10 year follow-up studyThe Science of The Total Environment · 2012
  • 5 shared tags